Pearl Therapeutics Closes $65M Series D

Pearl Therapeutics Inc., a biopharma company, has raised $65 million in Series D financing from current investors including 5AM Ventures, Clarus Ventures and New Leaf Venture Partners. Vatera Healthcare Partners led the round. With this infusion, Pearl will have raised a total of $167.5 million since 2007.

North AmericaUSBriefs